厂商 ：东莞康润仪器设备有限公司
广东 东莞- 主营产品：
- 玻璃器皿
- 样品前处理装置
- 标准物质
联系电话 ：13925770466
商品详细描述
| MM0142.00 | 苄达明盐酸盐 | 500mg | 12953 | Benzydamine Hydrochloride | 含量测定 | |
| MM0142.04 | 苄达明盐酸盐杂质C | 100mg | 12953 | Benzydamine Hydrochloride Imp. C (BP): 1-Benzyl-1H-indazol-3-ol | 含量测定 | |
| MM0142.08 | 苄达明氮氧化物盐酸盐 | 100mg | 12953 | Benzydamine N-Oxide Hydrochloride | 含量测定 | |
| MM0144.00 | 盐酸氯胺酮 | 500mg | 12953 | Ketamine Hydrochloride | 含量测定 | |
| MM0144.01 | 盐酸氯胺酮杂质A | 100mg | 12953 | Ketamine Hydrochloride Imp. A (EP): 1-[(2-Chlorophenyl)-(methylimino)methyl]cyclopentanol | 含量测定 | |
| MM0144.02 | 盐酸氯胺酮杂质B | 100mg | 12953 | Ketamine Hydrochloride Imp. B (EP): (2RS)-2-(2-Chloro-phenyl)-2-hydroxycyclohexanone | 含量测定 | |
| MM0144.07 | 去氢去甲基氯胺酮盐酸盐 | 50mg | 12953 | Dehydronorketamine Hydrochloride | 含量测定 | |
| MM0145.00 | 酮康唑 | 500mg | 12953 | Ketoconazole | 含量测定 | |
| MM0145.04 | 酮康唑 | 100mg | 12953 | Ketoconazole Imp. D (EP): 1-[4-[[(2RS,4SR)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine | 含量测定 | |
| MM0146.00 | 美西律 | 500mg | 12953 | Mexiletine Hydrochloride | 含量测定 | |
| MM0146.01 | 美西律杂质A | 100mg | 12953 | Mexiletine Hydrochloride Imp. A (EP): 2,6-Dimethylphenol | 含量测定 | |
| MM0146.02 | 美西律杂质B | 100mg | 12953 | Mexiletine Hydrochloride Imp. B (EP): 1-(2,6-Dimethylphenoxy)propan-2-one | 含量测定 | |
| MM0147.00 | 盐酸米安色林 | 100mg | 12953 | Mianserin Hydrochloride | 含量测定 | |
| MM0147.01 | 盐酸米安色林杂质A | 100mg | 12953 | Mianserin HCl Imp. A (EP): [2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]phenyl]methanol | 含量测定 | |
| MM0147.04 | 盐酸米安色林杂质C | 100mg | 4950 | Mianserin Hydrochloride Imp. C (EP): (2-Aminophenyl)methanol | 含量测定 | |
| MM0147.06 | 盐酸米安色林 | 100mg | 26235 | Mianserin N-Oxide | 含量测定 | |
| MM0149.00 | 佐匹克隆 | 100mg | 26235 | Zopiclone | 含量测定 | |
| MM0149.01 | 佐匹克隆杂质A | 100mg | 26235 | Zopiclone Imp. A (EP): (5RS)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-Methylpiperazine-1-carboxylate 4-Oxide (Zopiclone Oxide) | 含量测定 | |
| MM0149.02 | 佐匹克隆杂质B | 100mg | 26235 | Zopiclone Imp. B (EP): (7RS)-6-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo-[3,4-b]pyrazin-5-one | 含量测定 | |
| MM0150.00 | 噻氯吡啶 | 500mg | 12953 | Ticlopidine Hydrochloride | 含量测定 | |
| MM0150.01 | 噻氯吡啶杂质C | 100mg | 12953 | Ticlopidine Hydrochloride Imp. C (EP) as Hydrochloride: (2-Chlorophenyl)methanamine Hydrochloride | 含量测定 | |
| MM0150.06 | 噻氯吡啶杂质B | 100mg | 12953 | Ticlopidine Hydrochloride Imp. B (EP): 6,7-Dihydrothieno[3,2-c]pyridin-4(5H)-one | 含量测定 | |
| MM0150.07 | 噻氯吡啶杂质D | 100mg | 12953 | Ticlopidine Hydrochloride Imp. D (EP) as Hydrochloride: 5-Benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride | 含量测定 | |
| MM0150.08 | 噻氯吡啶杂质G | 100mg | 12953 | Ticlopidine Hydrochloride Imp. G (EP) as Hydrochloride: 5-(3-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride | 含量测定 | |
| MM0150.09 | 噻氯吡啶杂质H | 50mg | 6105 | Ticlopidine Hydrochloride Imp. H (EP) as Hydrochloride: 5-(4-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Hydrochloride | 含量测定 | |
| MM0150.10 | 噻氯吡啶杂质J | 100mg | 12953 | Ticlopidine Hydrochloride Imp. J (EP) as Dihydrochloride: N,N-Bis(2-chlorobenzyl)ethane-1,2-diamine Dihydrochloride | 含量测定 | |
| MM0150.11 | 噻氯吡啶杂质I | 100mg | 12953 | Ticlopidine Hydrochloride Imp. I (EP) as Hydrochloride: N-(2-Chlorobenzyl)-2-(thiophen-2-yl)ethanamine Hydrochloride | 含量测定 | |
| MM0150.12 | 噻氯吡啶杂质A | 100mg | 12953 | Ticlopidine Hydrochloride Imp. A (EP): Thieno[3,2-c]pyridine | 含量测定 | |
| MM0152.00 | 萘普生 | 500mg | 12953 | Naproxen | 含量测定 | |
| MM0152.01 | 萘普生 | 100mg | 12953 | (6-Methoxynaphthalen-2-yl)acetic Acid (a-Demethylnaproxen) | 含量测定 | |
| MM0152.02 | 萘普生杂质E | 100mg | 12953 | Naproxen Imp. E (EP): Methyl (2S)-2-(6-Methoxy-naphthalen-2-yl)propanoate (Naproxen Methyl Ester) | 含量测定 | |
| MM0152.04 | 萘普生钠 | 500mg | 12953 | Naproxen Sodium | 含量测定 | |
| MM0152.06 | 萘普生杂质A | 100mg | 12953 | Naproxen Imp. A (EP): (2S)-2-(6-Hydroxynaphthalen-2-yl)propanoic Acid(O-Demethylnaproxen) | 含量测定 | |
| MM0152.07 | 萘普生杂质L | 100mg | 4950 | Naproxen Imp. L (EP): 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin) | 含量测定 | |
| MM0152.08 | 萘普生杂质M | 100mg | 4950 | Naproxen Imp. M (EP): 2-Methoxynaphthalene (Nerolin) | 含量测定 | |
| MM0152.09 | 萘普生杂质B | 100mg | 12953 | Naproxen Imp. B (EP): (2S)-2-(5-Chloro-6-methoxy-naphthalen-2-yl)propanoic Acid(5-Chloronaproxene) | 含量测定 | |
| MM0152.10 | 萘普生杂质C | 100mg | 12953 | Naproxen Imp. C (EP): (2S)-2-(5-Bromo-6-methoxy-naphthalen-2-yl)propanoic Acid(5-Bromonaproxene) | 含量测定 | |
| MM0152.11 | 萘普生杂质D | 100mg | 12953 | Naproxen Imp. D (EP): (2S)-2-(5-Iodo-6-methoxy-naphthalen-2-yl)propanoic Acid(5-Iodonaproxene) | 含量测定 | |
| MM0152.12 | 萘普生杂质F | 100mg | 12953 | Naproxen Imp. F (EP): Ethyl (2S)-2-(6-Methoxy-naphthalen-2-yl)propanoate (Naproxen Ethyl Ester) | 含量测定 | |
| MM0152.14 | 萘普生杂质H | 100mg | 12953 | Naproxen Imp. H (EP): 6-Methoxynaphthalen-2-ol (Hydroxynerolin) | 含量测定 | |
| MM0152.16 | 萘普生杂质K | 100mg | 12953 | Naproxen Imp. K (EP): (1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol | 含量测定 | |
| MM0152.17 | 萘普生杂质N | 100mg | 6105 | Naproxen Imp. N (EP):2-Bromo-6-methoxynaphthalene | 含量测定 | |
| MM0152.18 | 萘普生杂质J | 100mg | 12953 | Naproxen Imp. J (EP): 2-Ethyl-6-methoxynaphthalene (Ethylnerolin) | 含量测定 | |
| MM0153.00 | 萘丁美酮 | 500mg | 12953 | Nabumetone | 含量测定 | |
| MM0153.02 | 萘丁美酮杂质A | 100mg | 12953 | Nabumetone Imp. A (EP): 3-(6-Methoxynaphthalen-2-yl)-5-methylcyclohexanone | 含量测定 | |
| MM0153.03 | 萘丁美酮杂质B | 100mg | 12953 | Nabumetone Imp. B (EP): (5RS)-5-(6-Methoxynaphthalen-2-yl)-3-methylcyclohex-2-enone | 含量测定 | |
| MM0153.04 | 萘丁美酮杂质C | 100mg | 12953 | Nabumetone Imp. C (EP): (2RS)-4-(6-Methoxynaphthalen-2-yl)-butan-2-ol | 含量测定 | |
| MM0153.05 | 萘丁美酮杂质D | 100mg | 12953 | Nabumetone Imp. D (EP): (E)-4-(6-Methoxynaphthalen-2-yl)-but-3-en-2-one | 含量测定 | |
| MM0153.07 | 萘丁美酮杂质F | 100mg | 12953 | Nabumetone Imp. F (EP): 6,6-Dimethoxy-2,2-binaphthalenyl | 含量测定 | |
| MM0155.00 | 哌海茶碱 | 100mg | 12953 | Piprinhydrinate | 含量测定 | |
| MM0155.01 | 二苯拉林 | 100mg | 12953 | Diphenylpyraline | 含量测定 | |
| MM0155.02 | 8-氯茶碱 | 100mg | 4950 | 8-Chlorotheophylline | 含量测定 | |
| MM0156.00 | 盐酸黄酮哌酯 | 100mg | 12953 | Flavoxate Hydrochloride | 含量测定 | |
| MM0156.01 | 盐酸黄酮哌酯杂质A | 100mg | 12953 | Flavoxate Hydrochloride Imp. A (EP): 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic Acid (3-Methyl-flavone-8-carboxylic Acid) | 含量测定 | |
| MM0156.02 | 盐酸黄酮哌酯杂质B | 100mg | 12953 | Flavoxate Hydrochloride Imp. B (EP): Ethyl 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate (3-Methyl-flavone-8-carboxylic Acid Ethyl Ester) | 含量测定 | |
| MM0156.05 | 盐酸黄酮哌酯杂质C | 50mg | 12953 | Flavoxate Hydrochloride Imp. C (EP): 1-Methylethyl 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate(3-Methylflavone-8-carboxylic Acid Isopropyl Ester) | 含量测定 | |
| MM0157.00 | 哌嗪丙二酸氢盐 | 100mg | 12953 | Perazine Dimalonate | 含量测定 | |
| MM0157.01 | 哌嗪亚砜 | 100mg | 12953 | Perazine Sulphoxide | 含量测定 | |
| MM0157.02 | 吩噻嗪 | 100mg | 4950 | Phenothiazine | 含量测定 | |
| MM0158.00 | 辛伐他汀 | 100mg | 12953 | Simvastatin | 含量测定 | |
| MM0158.01 | 辛伐他汀杂质A | 100mg | 12953 | Simvastatin Imp. A (EP) as Sodium Salt: (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt(Tenivastatin Sodium Salt; Simvastatin Hydroxy Acid Sodium S | 含量测定 | |
| MM0158.02 | 辛伐他汀杂质B | 100mg | 12953 | Simvastatin Imp. B (EP): (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-Dimethylbutanoate (Simvastatin Acetate Ester) | 含量测定 | |
| MM0158.03 | 辛伐他汀杂质C | 100mg | 12953 | Simvastatin Imp. C (EP): (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-Dimethylbutanoate (Anhydrosimvastatin) | 含量测定 | |
| MM0160.00 | 青霉素钾盐 | 250mg | 12953 | Benzylpenicillin Potassium | 含量测定 | |
| MM0160.03 | 苯乙酸 | 100mg | 4950 | Phenylacetic Acid DRUG PRECURSOR | 含量测定 | |
| MM0161.00 | 氟他胺 | 500mg | 12953 | Flutamide | 含量测定 | |
| MM0161.01 | 氟他胺 | 100mg | 12953 | 2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide) | 含量测定 | |
| MM0161.03 | 氟他胺杂质A | 100mg | 12953 | Flutamide Imp. A (EP): 4-Nitro-3-(trifluoromethyl)aniline | 含量测定 | |
| MM0161.04 | 氟他胺杂质B | 100mg | 12953 | Flutamide Imp. B (EP): N-[4-Nitro-3-(trifluoromethyl)-phenyl]acetamide | 含量测定 | |
| MM0161.05 | 氟他胺杂质C | 100mg | 12953 | Flutamide Imp. C (EP): N-[4-Nitro-3-(trifluoromethyl)-phenyl]propanamide | 含量测定 | |
| MM0161.06 | 3-（三氟甲基）苯胺 | 100mg | 4950 | 3-(Trifluoromethyl)aniline | 含量测定 | |
| MM0161.07 | 氟他胺杂质E | 100mg | 12953 | Flutamide Imp. E (EP): 2-Methyl-N-[3-(trifluoromethyl)phenyl]propanamide | 含量测定 | |
| MM0161.08 | 氟他胺杂质F | 100mg | 26235 | Flutamide Imp. F (EP): 2-Methyl-N-[2-nitro-5-(trifluoromethyl)phenyl]propanamide | 含量测定 | |
| MM0161.09 | 三氟甲基苯 | 100mg | 4950 | Trifluoromethylbenzene | 含量测定 | |
| MM0161.10 | 3-三氟化甲基硝基苯 | 100mg | 4950 | 3-Nitrobenzotrifluoride | 含量测定 | |
| MM0162.00 | 醋酸氯己啶 | 500mg | 12953 | Chlorhexidine Diacetate | 含量测定 | |
| MM0162.05 | 对氯苯胺 | 100mg | 4950 | 4-Chloroaniline | 含量测定 | |
| MM0163.12 | (+)-(R)-胡薄荷酮 | 100mg | 12953 | (+)-(R)-Pulegone | 含量测定 | |
| MM0164.01 | 反式茴香脑 | 100mg | 6105 | trans-Anethole | 含量测定 | |
| MM0164.02 | 草蒿脑 | 100mg | 6105 | Estragole | 含量测定 | |
| MM0164.03 | 茴香醛 | 100mg | 6105 | Anisaldehyde | 含量测定 | |
| MM0164.05 | 芳樟醇 | 100mg | 6105 | Linalol | 含量测定 | |
| MM0164.06 | 顺式茴香脑 | 100mg | 26235 | cis-Anethole | 含量测定 | |
| MM0166.00 | L-抗坏血酸 | 500mg | 12953 | L-Ascorbic Acid | 含量测定 | |
| MM0168.00 | 洛沙坦 | 100mg | 12953 | Losartan | 含量测定 | |
| MM0168.05 | 洛沙坦钾杂质E | 50mg | 12953 | Losartan Potassium Imp. E (EP): 5-(4-Methylbiphenyl-2-yl)-1H-tetrazole | 含量测定 | |
| MM0168.08 | 洛沙坦钾杂质D | 100mg | 12953 | Losartan Potassium Imp. D (EP) : 2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde | 含量测定 | |
| MM0168.11 | 洛沙坦丁醚 | 50mg | 12953 | Losartan Butyl Ether | 含量测定 | |
| MM0168.12 | 洛沙坦甲醚 | 100mg | 12953 | Losartan Methyl Ether | 含量测定 | |
| MM0168.15 | 洛沙坦杂质F | 100mg | 12953 | Losartan Potassium Imp. F (EP) : 5-[4[[2-Butyl-4-chloro-5-[[(1-methylethyl)oxy]methyl]-1H-imidazol-1-yl]-methyl]biphenyl-2-yl]-1H-tetrazole (Losartan Isopropyl Ether) | 含量测定 | |
| MM0168.16 | 洛沙坦杂质H | 100mg | 12953 | Losartan Potassium Imp. H (EP) : [2-Butyl-4-chloro-1-[[2-[2-(triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methanol | 含量测定 | |
| MM0168.18 | 洛沙坦杂质J | 100mg | 12953 | Losartan Potassium Imp. J (EP) : [2-Butyl-4-chloro-1-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl Acetate | 含量测定 | |
| MM0169.00 | L-谷氨酰胺 | 500mg | 12953 | L-Glutamine | 含量测定 | |
| MM0169.02 | 苯乙酰胺 | 100mg | 12953 | Phenylacetamide | 含量测定 | |
| MM0169.03 | D-谷氨酸 | 100mg | 12953 | D-Glutamine | 含量测定 | |
| MM0171.00 | 盐酸安他唑啉 | 500mg | 12953 | Antazoline Hydrochloride | 含量测定 | |
| MM0171.01 | 盐酸安他唑啉杂质A | 100mg | 12953 | Antazoline Dihydrochloride Imp. A (EP) as Dihydrochloride: N-(2-Aminoethyl)-2-(benzylphenylamino)-acetamide Dihydrochloride | 含量测定 | |
| MM0171.03 | N-苄基苯胺 | 100mg | 4950 | N-Benzylaniline | 含量测定 | |
| MM0172.00 | L-色氨酸 | 500mg | 12953 | L-Tryptophan | 含量测定 | |
| MM0172.03 | 5-羟基色氨 | 100mg | 12953 | 5-Hydroxytryptophan | 含量测定 | |
| MM0172.09 | L-色氨酸杂质A | 100mg | 26235 | L-Tryptophan Imp. A (EP):3,3-[Ethylidenebis(1H-indole-1,3-diyl)]bis[(2S)-2-aminopropanoic] Acid (1,1-Ethylidenebistryptophan) | 含量测定 | |
| MM0172.13 | N-乙酰色氨 | 100mg | 12953 | N-Acetyltryptophan | 含量测定 | |
| MM0173.04 | 三苯甲醇 | 100mg | 12953 | Triphenylmethanol | 含量测定 | |
| MM0175.00 | 氟桂利嗪 | 500mg | 12953 | Flunarizine Dihydrochloride | 含量测定 | |
| MM0175.03 | 氟桂利嗪杂质C | 100mg | 12953 | Flunarizine Dihydrochloride Imp. C (EP) as Dihydrochloride: 1-[(RS)-(2-Fluorophenyl)(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-enyl]piperazineDihydrochloride | 含量测定 | |
| MM0175.04 | 氟桂利嗪杂质A | 100mg | 12953 | Flunarizine Dihydrochloride Imp. A (EP) : 1-[Bis(4-fluorophenyl)methyl]-piperazine | 含量测定 | |
| MM0175.06 | 氟桂利嗪氮氧化物二盐酸盐 | 100mg | 12953 | Flunarizine N-Oxide Dihydrochloride | 含量测定 | |
| MM0176.00 | 茶碱 | 500mg | 12953 | Theophylline | 含量测定 | |
| MM0176.04 | 1-甲基黄嘌呤 | 100mg | 26235 | 1-Methylxanthine | 含量测定 | |
| MM0176.05 | 7-甲基黄嘌呤 | 100mg | 12953 | 7-Methylxanthine | 含量测定 | |
| MM0177.00 | 盐酸羟甲唑啉 | 250mg | 12953 | Oxymetazoline Hydrochloride | 含量测定 | |
| MM0177.01 | 盐酸羟甲唑啉杂质A | 100mg | 12953 | Oxymetazoline Hydrochloride Imp. A (EP) as Hydrochloride:N-(2-Aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl)]acetamide Hydrochloride | 含量测定 | |
| MM0177.04 | 盐酸羟甲唑啉杂质D | 100mg | 12953 | Oxymetazoline Hydrochloride Imp. D (EP): [4-(1,1-Dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetic Acid | 含量测定 | |
| MM0177.05 | 盐酸羟甲唑啉杂质E | 100mg | 26235 | Oxymetazoline Hydrochloride Imp. E (EP): [4-(1,1-Dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetic Acid | 含量测定 | |
| MM0177.07 | 盐酸羟甲唑啉杂质C | 100mg | 12953 | Oxymetazoline Hydrochloride Imp. C (EP): 2-[4-(1,1-Dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetamide | 含量测定 | |
| MM0179.00 | 丁苯羟酸 | 500mg | 12953 | Bufexamac | 含量测定 | |
| MM0179.01 | 丁苯羟酸杂质A | 100mg | 12953 | Bufexamac Imp. A (EP): 2-(4-Butoxyphenyl)acetic Acid | 含量测定 | |
| MM0179.02 | 丁苯羟酸杂质B | 100mg | 12953 | Bufexamac Imp. B (EP): Methyl 2-(4-Butoxyphenyl)acetate | 含量测定 | |
| MM0179.03 | 丁苯羟酸杂质C | 100mg | 12953 | Bufexamac Imp. C (EP): Butyl 2-(4-Butoxyphenyl)acetate | 含量测定 | |
| MM0179.04 | 丁苯羟酸杂质D | 100mg | 12953 | Bufexamac Imp. D (EP): 2-(4-Butoxyphenyl)acetamide | 含量测定 | |
| MM0179.05 | 4-丁氧基苯乙酮 | 100mg | 12953 | 4-Butoxyacetophenone | 含量测定 | |
| MM0180.00 | 富马酸氢酮替芬 | 250mg | 12953 | Ketotifen Hydrogen Fumarate | 含量测定 | |
| MM0180.04 | 酮替芬 | 100mg | 12953 | Ketotifen | 含量测定 | |
| MM0180.07 | 富马酸氢酮替芬杂质D | 100mg | 12953 | Ketotifen Hydrogen Fumarate Imp. D (EP): 4-[(aRaS)-1-Methylpiperidin-4-ylidene]-4,9-dihydro-10H-benzo[4,5]-cyclohepta[1,2-b]thiophen-10-one N-Oxide (Ketotifen N-Oxide) | 含量测定 | |
| MM0180.08 | 富马酸氢酮替芬杂质B | 100mg | 12953 | Ketotifen Hydrogen Fumarate Imp. B (EP): (4RS)-10-Methoxy-4-(1-methyl-piperidin-4-yl)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ol | 含量测定 | |
| MM0180.12 | N-去甲基富马酸氢酮替芬 | 50mg | 12953 | N-Desmethylketotifen Hydrogen Fumarate | 含量测定 | |
| MM0181.00 | 醋氯酚酸 | 250mg | 12953 | Aceclofenac | 含量测定 | |
| MM0181.01 | 醋氯酚酸杂质D | 100mg | 12953 | Aceclofenac Imp. D (EP): Methyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]-acetate (Methyl Ester of Aceclofenac) | 含量测定 | |
| MM0181.02 | 醋氯酚酸杂质E | 100mg | 12953 | Aceclofenac Imp. E (EP): Ethyl [[[2-[(2,6-Dichloro-phenyl)amino]phenyl]acetyl]oxy]-acetate (Ethyl Ester of Aceclofenac) | 含量测定 | |
| MM0181.03 | 醋氯酚酸杂质F | 100mg | 12953 | Aceclofenac Imp. F (EP): Benzyl [[[2-[(2,6-Dichloro-phenyl)amino]phenyl]acetyl]oxy]acetate (Benzyl Ester of Aceclofenac) | 含量测定 | |
| MM0181.04 | 醋氯酚酸杂质G | 100mg | 12953 | Aceclofenac Imp. Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)-amino]phenyl]acetyl]oxy]acetyl]oxy]acetic Acid (Acetic Aceclofenac) | 含量测定 | |
| MM0184.00 | 阿司咪唑 | 250mg | 12953 | Astemizole | 含量测定 | |
| MM0184.13 | 去甲阿司咪唑盐酸盐 | 10mg | 4950 | Desmethyl Astemizole Hydrochloride | 含量测定 | |
| MM0185.00 | 氢化可的松 | 500mg | 12953 | Hydrocortisone | 含量测定 | |
| MM0185.06 | 氢化可的松杂质D | 100mg | 12953 | Hydrocortisone Imp. D (EP): 6b,11b,17,21-Tetrahydroxy-pregn-4-ene-3,20-dione(6b-Hydroxyhydrocortisone) | 含量测定 | |
| MM0185.07 | 氢化可的松杂质E | 100mg | 26235 | Hydrocortisone Imp. E (EP): 11b,17,21-Trihydroxypregna-4,6-diene-3,20-dione (Delta 6-Hydrocortisone) | 含量测定 | |
| MM0185.08 | 氢化可的松杂质F | 100mg | 12953 | Hydrocortisone Imp. F (EP): 17,21-Dihydroxypregn-4-ene-3,20-dione (Reichsteins Substance S) | 含量测定 | |
| MM0186.00 | 醋酸可的松 | 500mg | 12953 | Cortisone Acetate | 含量测定 | |
| MM0187.00 | 醋酸氢化可的松 | 500mg | 12953 | Hydrocortisone Acetate | 含量测定 | |
| MM0188.00 | 17-丁酸氢化可的松 | 500mg | 12953 | Hydrocortisone 17-Butyrate | 含量测定 | |
| MM0188.01 | 21-丁酸氢化可的松 | 100mg | 12953 | Hydrocortisone 21-Butyrate | 含量测定 | |
| MM0190.00 | 甲泼尼松龙 | 100mg | 12953 | Methylprednisolone | 含量测定 | |
| MM0190.01 | 甲泼尼松龙杂质A | 50mg | 26235 | Methylprednisolone Imp. A (EP): 17,21-Dihydroxy-6*-methylpregna-1,4-diene-3,11,20-trione | 含量测定 | |
| MM0191.00 | 甲泼尼龙醋酸酯 | 100mg | 26235 | Methylprednisolone Acetate | 含量测定 | |
| MM0192.00 | 甲基氢化泼尼松琥珀酸盐 | 100mg | 26235 | Methylprednisolone Hydrogen Succinate Sodium Salt | 含量测定 | |
| MM0193.00 | 泼尼松龙 | 500mg | 12953 | Prednisolone | 含量测定 | |
| MM0194.00 | 醋酸泼尼松龙 | 500mg | 12953 | Prednisolone Acetate | 含量测定 | |
| MM0196.00 | 醋酸泼尼松 | 250mg | 12953 | Prednisone Acetate | 含量测定 | |
| MM0197.00 | 螺内酯 | 500mg | 12953 | Spironolactone | 含量测定 | |
| MM0197.01 | 烯睾丙内酯 | 100mg | 12953 | 3,4-Dihydrospiro[androst-4,6-diene-17,2(5H)-furan]-3,5-dione (Canrenone) | 含量测定 | |
| MM0198.00 | 曲安奈德 | 250mg | 12953 | Triamcinolone Acetonide | 含量测定 | |
| MM0198.01 | 氟羟泼尼松龙 | 250mg | 12953 | Triamcinolone | 含量测定 | |
| MM0199.00 | 二丙酸倍氯米松 | 250mg | 12953 | Beclometasone Dipropionate | 含量测定 | |
| MM0199.01 | 二丙酸倍氯米松杂质H | 100mg | 12953 | Beclometasone Dipropionate Imp. H (EP): 9-Chloro-11b,21-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-17-ylPropanoate (Beclometasone 17-Propionate) | 含量测定 | |
| MM0199.02 | 二丙酸倍氯米松杂质A | 100mg | 12953 | Beclometasone Dipropionate Imp. A (EP): 9-Chloro-11b,17-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-21-ylPropanoate (Beclometasone 21-Propionate)Beclometasone Dipropionate | 含量测定 | |
| MM0199.03 | 倍氯米松 | 100mg | 12953 | 9-Chloro-11b,17,21-trihydroxy-16b-methylpregna-1,4-diene-3,20-dione (Beclometasone) | 含量测定 | |
| MM0199.06 | 二丙酸倍氯米松杂质B | 100mg | 12953 | Beclometasone Dipropionate Imp. B (EP): 21-(Acetyloxy)-9-chloro-11b-hydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-17-yl Propanoate (Beclometasone 21-Acetate 17-Propionate) | 含量测定 | |
| MM0200.00 | 倍他米松 | 250mg | 12953 | Betamethasone | 含量测定 | |
| MM0201.00 | 醋酸倍他米松 | 250mg | 12953 | Betamethasone Acetate | 含量测定 | |
| MM0201.03 | 醋酸倍他米松杂质C | 100mg | 12953 | Betamethasone Acetate Imp. C (EP): Betamethasone 11,21-Diacetate | 含量测定 | |
| MM0202.00 | 二丙酸倍他米松 | 250mg | 12953 | Betamethasone Dipropionate | 含量测定 | |
| MM0202.04 | 21-丙酸倍他米松 | 100mg | 12953 | Betamethasone 21-Propionate | 含量测定 | |
| MM0203.00 | 17-倍他米松戊酸酯 | 250mg | 12953 | Betamethasone 17-Valerate | 含量测定 | |
| MM0204.01 | 布地奈德杂质A | 100mg | 12953 | Budesonide Imp. A (EP): 11b,16a,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione (16a-Hydroxy-prednisolone) | 含量测定 | |
| MM0204.02 | 布地奈德杂质B | 50mg | 12953 | Budesonide Imp.B (EP): 16a,17-[(1RS)-Ethylidenebis(oxy)]-11b,21-dihydroxypregna-1,4-diene-3,20-dione | 含量测定 | |
| MM0209.00 | 戊酸雌二醇 | 500mg | 12953 | Estradiol Valerate | 含量测定 | |
| MM0209.01 | 戊酸雌二醇杂质C | 100mg | 26235 | Estradiol Valerate Imp. C (EP): 3-Hydroxyestra-1,3,5(10),9(11)-tetraen-17b-yl Pentanoate(9,11-Didehydroestradiol Valerate) | 含量测定 | |
| MM0209.02 | 戊酸雌二醇杂质E | 100mg | 12953 | Estradiol Valerate Imp. E (EP): Estra-1,3,5(10)-trien-3,17b-diyl Dipentanoate(Estradiol 3,17-Divalerate) | 含量测定 | |
| MM0209.04 | 戊酸雌二醇杂质F | 100mg | 12953 | Estradiol Valerate Imp. F (EP): 3-Hydroxyestra-1,3,5(10)-trien-17b-yl Butanoate(Estradiol Butyrate) | 含量测定 | |
| MM0209.06 | 戊酸雌二醇杂质B | 100mg | 12953 | Estradiol Valerate Imp. B (EP): 17b-Hydroxyestra-1,3,5(10)-trien-3-yl Pentanoate(Estradiol 3-Valerate) | 含量测定 | |
| MM0209.07 | 戊酸雌二醇杂质D | 100mg | 26235 | Estradiol Valerate Imp. D (EP): 3-Hydroxy-4-methylestra-1,3,5(10)-trien-17b-yl Pentanoate(4-Methylestradiol Valerate) | 含量测定 | |
| MM0210.00 | 地塞米松磷酸钠 | 250mg | 12953 | Dexamethasone Sodium Phosphate | 含量测定 | |
| MM0212.00 | 地高辛 | 250mg | 12953 | Digoxin | 含量测定 | |
| MM0213.00 | 地塞米松 | 250mg | 12953 | Dexamethasone | 含量测定 | |
| MM0213.01 | 地塞米松杂质C | 50mg | 26235 | Dexamethasone Imp. C (Pharmeuropa): 9-a-Fluoro-11b,17a,21-trihydroxy-16a-methylpregn-4-ene-3,20-dione | 含量测定 | |
| MM0214.00 | 可的松 | 500mg | 12953 | Cortisone | 含量测定 | |
| MM0215.00 | 醋酸环丙孕酮 | 250mg | 12953 | Cyproterone Acetate | 含量测定 | |
| MM0217.00 | 美沙拉秦 | 500mg | 12953 | Mesalazine | 含量测定 | |
| MM0217.02 | 5-乙酰胺基水杨酸 | 100mg | 12953 | 5-Acetaminosalicylic Acid | 含量测定 | |
| MM0217.06 | 美沙拉秦杂质C | 100mg | 12953 | Mesalazine Imp. C (EP): 2-Aminophenol | 含量测定 | |
| MM0217.07 | 美沙拉秦杂质D | 100mg | 12953 | Mesalazine Imp. D (EP): 3-Aminobenzoic Acid | 含量测定 | |
| MM0217.09 | 美沙拉秦杂质F | 100mg | 12953 | Mesalazine Imp. F (EP): 3-Amino-2-hydroxybenzoicAcid (3-Aminosalicylic Acid) | 含量测定 | |
| MM0217.10 | 美沙拉秦杂质G | 100mg | 12953 | Mesalazine Imp. G (EP): 2,5-Dihydroxybenzoic Acid | 含量测定 | |
| MM0217.14 | 2-氯苯甲酸 | 100mg | 12953 | 2-Chlorobenzoic Acid | 含量测定 | |
| MM0217.15 | 美沙拉秦杂质M | 100mg | 12953 | Mesalazine Imp. M (EP): 2-Chloro-5-nitrobenzoic Acid | 含量测定 | |
| MM0217.16 | 美沙拉秦杂质N | 100mg | 12953 | Mesalazine Imp. N (EP): 2-Hydroxy-5-nitrobenzoic Acid(5-Nitrosalicylic Acid) | 含量测定 | |
| MM0218.00 | 炔诺酮 | 250mg | 12953 | Norethisterone | 含量测定 | |
| MM0218.01 | 炔诺酮杂质H | 100mg | 26235 | Norethisterone Imp. H (EP): 6b,17-Dihydroxy-19-nor-17a-pregn-4-en-20-yn-3-one (6b-Hydroxynorethisterone) | 含量测定 | |
| MM0218.04 | 炔诺酮杂质A | 100mg | 26235 | Norethisterone Imp. A (EP): 17-Hydroxy-19-nor-17a-pregna-4,6-dien-20-yn-3-one (6,7-Didehydronorethisterone) | 含量测定 | |
| MM0219.00 | 醋酸炔诺酮 | 100mg | 12953 | Norethisterone Acetate | 含量测定 | |
| MM0219.01 | 醋酸炔诺酮杂质F | 100mg | 26235 | Norethisterone Acetate Imp. F (EP): 6b-Hydroxy-3-oxo-19-nor-17a-pregn-4-en-20-yn-17-yl Acetate(6b-Hydroxynorethisterone Acetate) | 含量测定 | |
| MM0219.03 | 醋酸炔诺酮杂质G | 100mg | 26235 | Norethisterone Acetate Imp. G (EP): 3,6-Dioxo-19-nor-17a-pregn-4-en-20-yn-17-yl Acetate(6-Ketonorethisterone Acetate) | 含量测定 | |
| MM0219.10 | 醋酸炔诺酮杂质B | 100mg | 26235 | Norethisterone Acetate Imp. B (EP): 3-Oxo-19-nor-17alpha-pregn-5(10-en-20yn-17yl Acetate | 含量测定 | |
| MM0220.00 | 尼扎替丁 | 500mg | 12953 | Nizatidine | 含量测定 | |
| MM0220.01 | 尼扎替丁杂质A | 100mg | 12953 | Nizatidine Imp. A (EP): N,N-Dimethyl-2-nitroethene-1,1-diamine | 含量测定 | |
| MM0220.02 | 尼扎替丁杂质C | 50mg | 6105 | Nizatidine Imp. C (EP): (EZ)-N-[2-[[[2-[(Dimethylamino)methyl]thiazol-4-yl]methyl]sulphinyl]ethyl]-N-methyl-2-nitroethene-1,1-diamine | 含量测定 | |
| MM0220.11 | 尼扎替丁杂质H | 100mg | 12953 | Nizatidine Imp. H (EP) as Hydrochloride: 2-(Dimethylamino)thioacetamide Hydrochloride | 含量测定 | |
| MM0222.00 | 孕酮 | 500mg | 12953 | Progesterone | 含量测定 | |
| MM0222.01 | 孕酮杂质E | 100mg | 26235 | Progesterone Imp. E (EP): (20R)-3-Oxopregn-4-en-20yl Acetate | 含量测定 | |
| MM0222.03 | 孕酮杂质C | 100mg | 12953 | Progesterone Imp. C (EP): (20R)-20-Hydroxypregn-4-en-3-one | 含量测定 | |
| MM0222.14 | 孕二醇 | 100mg | 12953 | Pregnanediol (5b-Pregnane-3a,20(S)-diol) | 含量测定 | |
| MM0222.15 | 孕三醇 | unit | 26235 | Pregnanetriol (5b-Pregnane-3a,17,20(S)-triol) | 含量测定 | |
| MM0224.00 | 苯扎氯胺 | 500mg | 12953 | Benzalkonium Chloride | 含量测定 | |
| MM0227.00 | 磺胺甲噁唑 | 500mg | 12953 | Sulfamethoxazole | 含量测定 | |
| MM0227.01 | 磺胺甲噁唑杂质A | 100mg | 12953 | Sulfamethoxazole Imp. A (EP): N-[4-[(5-Methylisoxazol-3-yl)-sulphamoyl]phenyl]acetamide | 含量测定 | |
| MM0227.02 | 磺胺甲噁唑杂质C | 100mg | 4950 | Sulfamethoxazole Imp. C (EP): 5-Methylisoxazol-3-amine | 含量测定 | |
| MM0227.03 | 磺胺甲噁唑杂质B | 100mg | 12953 | Sulfamethoxazole Imp. B (EP): 4-[[(4-Aminophenyl)sulphonyl]-amino]-N-(5-methylisoxazol-3-yl)benzene-sulphonamide | 含量测定 | |
| MM0227.04 | 磺胺酸 | 100mg | 12953 | Sulphanilic Acid | 含量测定 | |
| MM0227.05 | 对氨基苯磺酰胺 | 100mg | 12953 | 4-Aminobenzenesulphonamide (Sulphanilamide) | 含量测定 | |
| MM0228.00 | 氧氟沙星 | 500mg | 12953 | Ofloxacin | 含量测定 | |
| MM0228.04 | 氧氟沙星杂质A | 100mg | 12953 | Ofloxacin Imp. A (EP): (RS)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (FPA) | 含量测定 | |
| MM0228.05 | 氧氟沙星杂质B | 100mg | 12953 | Ofloxacin Imp. B (EP): (RS)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-2,3-dihydro-7H-pyrido-[1,2,3-de]-1,4-benzoxazin-7-one | 含量测定 | |
| MM0228.08 | 氧氟沙星杂质E | 100mg | 12953 | Ofloxacin Imp. E (EP): (RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid | 含量测定 | |
| MM0228.10 | 氧氟沙星杂质F | 100mg | 12953 | Ofloxacin Imp. F (EP) as Hydrochloride: 4-[(RS)-6-Carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-10-yl]-1-methylpiperazine 1-Oxide Hydrochloride (Ofloxacin N-Oxide Hydrochloride) | 含量测定 | |
| MM0229.00 | 单水双氯西林钠 | 500mg | 26235 | Dicloxacillin Sodium Monohydrate | 含量测定 | |
| MM0232.00 | 阿莫西林三水物 | 500mg | 12953 | Amoxicillin Trihydrate | 含量测定 | |
| MM0232.02 | L-阿莫西林 | 100mg | 26235 | (2S,5R,6R)-6-[[(2S)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (L-Amoxicillin) | 含量测定 | |
| MM0232.03 | 阿莫西林三水物杂质C | 100mg | 12953 | Amoxicillin Trihydrate Imp. C (EP): (4S)-2-[5-(4-Hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethyl-thiazolidine-4-carboxylic Acid (Amoxicillin Diketopiperazines) | 含量测定 | |
| MM0232.04 | 阿莫西林三水物杂质D | 100mg | 12953 | Amoxicillin Trihydrate Imp. D (EP) as Sodium Salt:(4S)-2-[[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-carboxymethyl]-5,5-dimethylthiazolidine-4-carboxylic Acid Sodium Salt (PenicilloicAcids of Amoxicillin Sodium Salt) | 含量测定 | |
| MM0232.05 | 阿莫西林三水物杂质E | 50mg | 12953 | Amoxicillin Trihydrate Imp. E (EP): (2RS,4S)-2-[[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penilloic Acids of Amoxicillin) | 含量测定 | |
| MM0232.06 | 阿莫西林三水物杂质F | 100mg | 12953 | Amoxicillin Trihydrate Imp. F (EP): 3-(4-Hydroxyphenyl)pyrazin-2-ol | 含量测定 | |
| MM0232.08 | 阿莫西林三水物杂质H | 100mg | 12953 | Amoxicillin Trihydrate Imp. H (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-(4-hydroxyphenyl)acetic Acid | 含量测定 | |
| MM0233.00 | 盐酸纳曲酮 | 100mg | 12953 | Naltrexone Hydrochloride | 含量测定 | |
| MM0235.00 | 氟康唑 | 100mg | 12953 | Fluconazole | 含量测定 | |
| MM0235.02 | 氟康唑杂质F | 50mg | 12953 | Fluconazole Imp. F (EP): (2RS)-2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol | 含量测定 | |
| MM0235.11 | 氟康唑杂质A | 100mg | 12953 | Fluconazole Imp. A (EP): | 含量测定 | |
| MM0235.12 | 氟康唑杂质B | 100mg | 26235 | Fluconazole Imp. B (EP): 2-[2-Fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol | 含量测定 | |
| MM0235.13 | 氟康唑杂质C | 50mg | 12953 | Fluconazole Imp. C (EP): 1,1-(1,3-Phenylene)di-1H-1,2,4-triazole | 含量测定 | |
| MM0235.14 | 氟康唑杂质D | 100mg | 12953 | Fluconazole Imp. D (EP): 2-(4-Fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol | 含量测定 | |
| MM0236.00 | 羧甲司坦 | 500mg | 12953 | Carbocisteine | 含量测定 | |
| MM0236.03 | L-半胱亚磺酸 | 100mg | 6105 | L-Cysteinesulfinic Acid | 含量测定 | |
| MM0237.00 | 盐酸苯海索 | 500mg | 12953 | Trihexyphenidyl Hydrochloride | 含量测定 | |
| MM0237.01 | 苯乙酮 | 100mg | 4950 | Acetophenone | 含量测定 | |
| MM0237.03 | 盐酸苯海索杂质A | 100mg | 12953 | Trihexyphenidyl Hydrochloride Imp. A (EP) as Hydrochloride: 1-Phenyl-3-(piperidin-1-yl)propan-1-one Hydrochloride | 含量测定 | |
| MM0237.04 | 苯海索氮氧化物 | 50mg | 6105 | Trihexyphenidyl N-Oxide | 含量测定 | |
| MM0238.00 | 头孢唑林钠 | 100mg | 12953 | Cefazolin Sodium | 含量测定 | |
| MM0238.05 | 头孢唑林钠 杂质E | 100mg | 12953 | Cefazolin Sodium Imp. E (EP): 5-Methyl-1,3,4-thiadiazol-2-thiol (MMTD) | 含量测定 | |
| MM0239.00 | 盐酸万古霉素 | 100mg | 12953 | Vancomycin Hydrochloride | 含量测定 | |
| MM0240.00 | 马来酸曲米帕明 | 500mg | 12953 | Trimipramine Maleate | 含量测定 | |
| MM0240.01 | 曲米帕明 | 100mg | 12953 | Trimipramine | 含量测定 | |
| MM0240.02 | 马来酸曲米帕明杂质B | 100mg | 12953 | Trimipramine Maleate Imp. B (EP) as Hydrochloride: (2RS)-3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,2-di-methylpropan-1-amine Hydrochloride (Desmethyltrimipramine Hydrochloride) | 含量测定 | |
| MM0240.04 | 马来酸曲米帕明杂质A | 100mg | 12953 | Trimipramine Maleate Imp. A (EP): (2RS)-3-(10,11-Dihydro-5H-dibenzo-[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine N-oxide (Trimipramine N-Oxide) | 含量测定 | |
| MM0242.00 | 氢溴酸西酞普兰 | 250mg | 12953 | Citalopram Hydrobromide | 含量测定 | |
| MM0242.09 | 氢溴酸西酞普兰杂质D | 100mg | 12953 | Citalopram Hydrobromide Imp. D (EP) as Hydrochloride: (1RS)-1-(4-Fluorophenyl)-1-[3-(methylamino)propyl]-1,3-dihydroisobenzofuran-5-carbonitrile Hydro-chloride (Desmethylcitalopram Hydrochloride) | 含量测定 | |
| MM0242.14 | 氢溴酸西酞普兰杂质A | 100mg | 12953 | Citalopram Hydrobromide Imp. A (EP): (1RS)-1-[3-(Dimethylamino)-propyl]-1-(4-fluorophenyl)-1,3-dihydro-isobenzofuran-5-carboxamide (Citalopram-Amide) | 含量测定 | |
| MM0242.17 | 氢溴酸西酞普兰杂质C | 100mg | 12953 | Citalopram Hydrobromide Imp. C (EP): (3RS)-6-Cyano-3-[3-(dimethyl-amino)propyl]-3-(4-fluorophenyl)isobenzofuran-1(3H)-one | 含量测定 | |
| MM0244.00 | 二甲基吗啡 | 100mg | 12953 | Thebaine [Controlled Substance] | 含量测定 | |
| MM0246.00 | 美洛昔康 | 500mg | 12953 | Meloxicam | 含量测定 | |
| MM0246.01 | 美洛昔康杂质B | 100mg | 12953 | Meloxicam Imp. B (EP): 5-Methylthiazol-2-amine | 含量测定 | |
| MM0247.01 | 替诺昔康杂质B | 100mg | 12953 | Tenoxicam Imp. B (EP): Methyl 4-Hydroxy-2-methyl-2H-thieno[2,3-e]1,2-thiazine-3-carboxylate 1,1-Dioxide | 含量测定 | |
| MM0247.04 | 替诺昔康杂质C | 100mg | 12953 | Tenoxicam Imp. C (EP): N-Methylthiophene-2-carboxamide | 含量测定 | |
| MM0247.06 | 替诺昔康杂质E | 100mg | 12953 | Tenoxicam Imp. E (EP): 2-Methylthieno[2,3-d]isothiazol-3(2H)-one 1,1-Dioxide | 含量测定 | |
| MM0249.02 | 维生素D3杂质B | 100mg | 12953 | Cholecalciferol Imp.B (EP):Cholesta-5,7-dien-3?-ol(7,8-Didehydrocholesterol, Provitamine D3) | 含量测定 | |
| MM0250.00 | 吗氯贝胺 | 100mg | 12953 | Moclobemide | 含量测定 | |
| MM0252.00 | 昂丹司琼盐酸盐单水合物 | 100mg | 12953 | Ondansetron Hydrochloride Dihydrate | 含量测定 | |
| MM0252.01 | 昂丹司琼盐酸盐单水合物杂质C | 100mg | 12953 | Ondansetron HCl Dihydrate Imp. C (EP): 9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | 含量测定 | |
| MM0252.02 | 昂丹司琼盐酸盐单水合物杂质B | 50mg | 26235 | Ondansetron HCl Dihydrate Imp. B (EP): 6,6-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)-methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one] | 含量测定 | |
| MM0252.03 | 昂丹司琼盐酸盐单水合物杂质A | 100mg | 12953 | Ondansetron HCl Dihydrate Imp. A (EP): (3RS)-3-(Dimethylamino)-methyl-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | 含量测定 | |
| MM0252.04 | 昂丹司琼盐酸盐单水合物杂质D | 100mg | 12953 | Ondansetron HCl Dihydrate Imp.D (EP): 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one | 含量测定 | |
| MM0252.06 | 昂丹司琼盐酸盐单水合物杂质F | 100mg | 4950 | Ondansetron HCl Dihydrate Imp. F (EP): 2-Methyl-1H-imidazole | 含量测定 | |
| MM0252.07 | 昂丹司琼盐酸盐单水合物杂质G | 100mg | 12953 | Ondansetron HCl Dihydrate Imp. G (EP): (3RS)-3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-Demethylondansetron) | 含量测定 | |
| MM0252.08 | 昂丹司琼盐酸盐单水合物杂质H | 100mg | 12953 | Ondansetron HCl Dihydrate Imp. H (EP): (3RS)-3-[(2-Methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one (N-Demethylondansetron) | 含量测定 | |
| MM0252.09 | 昂丹司琼 | 100mg | 12953 | Ondansetron | 含量测定 | |
| MM0253.00 | 氨苄西林钠 | 500mg | 12953 | Ampicillin Sodium | 含量测定 | |
| MM0253.02 | 氨苄西林钠杂质B | 100mg | 12953 | Ampicillin Sodium Imp. B (EP): | 含量测定 | |
| MM0253.03 | 氨苄西林钠杂质C | 100mg | 12953 | Ampicillin Sodium Imp. C (EP): (4S)-2-(3,6-Dioxo-5-phenylpiperazin-2-yl)-5,5-dimethylthiazolidine-4-carboxylic Acid (Diketopiperazines of Ampicillin) | 含量测定 | |
| MM0253.04 | 氨苄西林钠杂质D | 100mg | 12953 | Ampicillin Sodium Imp. D (EP) as Sodium Salt: | 含量测定 | |
| MM0253.06 | 氨苄西林钠杂质F | 100mg | 12953 | Ampicillin Sodium Imp. F (EP): (2RS,4S)-2-[[[(2R)-2-Amino-2-phenylacetyl]amino]methyl]-5,5-dimethyl-thiazolidine-4-carboxylic Acid(Penilloic Acids of Ampicillin) | 含量测定 | |
| MM0253.11 | 氨苄西林钠杂质K | 100mg | 12953 | Ampicillin Sodium Imp. K (EP): (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-phenylacetic Acid | 含量测定 | |
| MM0253.15 | 氨苄西林三水合物 | 500mg | 12953 | Ampicillin Trihydrate | 含量测定 | |
| MM0253.16 | 氨苄西林无水物 | 500mg | 12953 | Ampicillin, anhydrous | 含量测定 | |
| MM0254.00 | 枸橼酸西地那非 | 100mg | 26235 | Sildenafil Citrate | 含量测定 | |
| MM0256.00 | 盐酸氟西汀 | 50mg | 12953 | Fluoxetine Hydrochloride | 含量测定 | |
| MM0256.01 | 盐酸氟西汀杂质A | 100mg | 12953 | Fluoxetine Hydrochloride Imp. A (EP):(1RS)-3-(Methylamino)-1-phenylpropan-1-ol | 含量测定 | |
| MM0256.02 | 盐酸氟西汀杂质B | 100mg | 12953 | Fluoxetine Hydrochloride Imp. B (EP) as Hydrochloride:N-Methyl-3-phenylpropan-1-amine Hydrochloride Controlled Substance(Methyl-3-phenylpropylamin(1M-3PP)/(Methyl)(3-phenylpropyl)azan als Hydrochlorid) | 含量测定 | |
| MM0256.03 | 盐酸氟西汀杂质C | 100mg | 12953 | Fluoxetine Hydrochloride Imp. C (EP) as Hydrochloride : (3RS)-N-Methyl-3-phenyl-3-[3-(trifluoromethyl]phenoxy]propan-1-amine Hydrochloride | 含量测定 | |
| MM0256.05 | 对三氟甲基苯酚 | 100mg | 4950 | 4-Hydroxybenzotrifluoride | 含量测定 | |
| MM0256.06 | 4-氯三氟甲苯 | 100mg | 4950 | 4-Chlorobenzotrifluoride | 含量测定 | |
| MM0256.16 | N-甲酰基氟西汀 | 100mg | 12953 | N-Formylfluoxetine | 含量测定 | |
| MM0257.00 | 氯雷他定 | 100mg | 12953 | Loratadine | 含量测定 | |
| MM0257.01 | 氯雷他定杂质D | 50mg | 12953 | Loratadine Imp. D (EP): 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine;Desloratadine) | 含量测定 | |
| MM0257.02 | 氯雷他定杂质B | 100mg | 12953 | Loratadine Imp. B (EP): 8-Chloro-5,6-dihydro-11H-benzo[5.6]cyclohepta[1,2-b]pyridin-11-one | 含量测定 | |
| MM0257.03 | 氯雷他定杂质A | 100mg | 12953 | Loratadine Imp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclo-hepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate | 含量测定 | |
| MM0257.05 | 氯雷他定杂质G | 100mg | 12953 | Loratadine Imp. G (EP): 8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta-[1,2-b]pyridine | 含量测定 | |
| MM0257.07 | 氯雷他定杂质H | 100mg | 12953 | Loratadine Imp. H (EP): Ethyl 4-Oxopiperidine-1-carboxylate | 含量测定 | |
| MM0257.08 | 氯雷他定杂质C | 100mg | 26235 | Loratadine Imp. C (EP): Ethyl 4-(4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate | 含量测定 | |
| MM0258.00 | 伊曲康唑 | 100mg | 12953 | Itraconazole | 含量测定 | |
| MM0258.02 | 伊曲康唑杂质A | 100mg | 12953 | Itraconazole Imp. A (EP): 4-[4-[4-(4-Methoxyphenyl)piperazin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 含量测定 | |
| MM0258.04 | 伊曲康唑杂质C | 100mg | 12953 | Itraconazole Imp. C (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]-methoxy]phenyl]piperazin-1-yl]phenyl]-2-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one | 含量测定 | |
| MM0258.05 | 伊曲康唑杂质D | 100mg | 12953 | Itraconazole Imp. D (EP): 4-[4-[4-[4-[[cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]-methoxy]phenyl]piperazin-1-yl]phenyl]-2-(1-methylethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one | 含量测定 | |
| MM0258.07 | 伊曲康唑杂质F | 100mg | 12953 | Itraconazole Imp. F (EP): 2-Butyl-4-[4-[4-[4-[[cis-2-(2,4-dichloro-phenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 含量测定 | |
| MM0262.00 | 左旋多巴 | 500mg | 12953 | Levodopa | 含量测定 | |
| MM0262.05 | 左旋多巴杂质C | 100mg | 12953 | Levodopa Imp. C (EP): (2RS)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic Acid (3-Methoxy-DL-tyrosine; (DL)-3-O-Methyldopa) | 含量测定 | |
| MM0265.01 | 2-苯丁酰脲 | 100mg | 12953 | Phenylethylacetylurea (2-Phenylbutyrylurea) | 含量测定 | |
| MM0265.03 | 巴比妥酸 | 100mg | 6105 | Barbituric Acid | 含量测定 | |
| MM0266.00 | 左美丙嗪盐酸盐 | 500mg | 12953 | Levomepromazine Hydrochloride | 含量测定 | |
| MM0267.00 | 吗多明 | 250mg | 12953 | Molsidomine | 含量测定 | |
| MM0267.01 | 吗多明杂质C | 100mg | 12953 | Molsidomine Imp. C (EP): (2E)-(Morpholin-4-ylimino)acetonitrile | 含量测定 | |
| MM0267.02 | 吗多明杂质A | 100mg | 12953 | Molsidomine Imp. A (EP) as Hydrochloride: 3-(Morpholin-4-yl)sydnonimine Hydrochloride (Linsidomine Hydrochloride) | 含量测定 | |
| MM0267.03 | 吗多明杂质B | 100mg | 12953 | Molsidomine Imp. B (EP): 4-Nitrosomorpholine | 含量测定 | |
| MM0267.06 | 吗多明杂质E | 100mg | 12953 | Molsidomine Imp. E (EP): Morpholine | 含量测定 | |
| MM0269.00 | 氨苯蝶啶 | 500mg | 12953 | Triamterene | 含量测定 | |
| MM0269.02 | 氨苯蝶啶 | 100mg | 4950 | Triamterene Imp. A (EP): 5-Nitrosopyrimidine-2,4,6-triamine(Nitrosotriaminopyrimidine) | 含量测定 | |
| MM0272.00 | 二水合盐酸纳洛酮 | 250mg | 12953 | Naloxone Hydrochloride Dihydrate | 含量测定 | |
| MM0278.00 | 苯酰甲硝唑 | 100mg | 12953 | Metronidazole Benzoate | 含量测定 | |
| MM0278.01 | 苯甲酸 | 100mg | 4950 | Benzoic Acid | 含量测定 | |
| MM0279.00 | 琥珀酸美托洛尔 | 100mg | 12953 | Metoprolol Succinate | 含量测定 | |
| MM0280.00 | 硫酸吗啡 | 250mg | 12953 | Morphine Hemisulphate Pentahemihydrate [Controlled Substance] | 含量测定 | |
| MM0281.00 | 硝酸咪康唑 | 500mg | 12953 | Miconazole Nitrate | 含量测定 | |
| MM0281.03 | 硝酸咪康唑杂质C | 100mg | 26235 | Miconazole Nitrate Imp. C (EP) as Nitrate: (2RS)-2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine Nitrate | 含量测定 | |
| MM0281.06 | 硝酸咪康唑杂质F | 100mg | 12953 | Miconazole Nitrate Imp. F (EP) as Nitrate: 1-[(2RS)-2-[(3,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate | 含量测定 | |
| MM0281.07 | 硝酸咪康唑杂质G | 100mg | 12953 | Miconazole Nitrate Imp. G (EP) as Nitrate: 1-[(2RS)-2-[(2,5-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate | 含量测定 | |
| MM0281.08 | 硝酸咪康唑杂质H | 100mg | 12953 | Miconazole Nitrate Imp. H (EP) as Nitrate: 1-[(2RS)-2-Benzyloxy-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate | 含量测定 | |
| MM0281.09 | 硝酸咪康唑杂质I | 100mg | 12953 | Miconazole Nitrate Imp. I (EP) as Nitrate: 1-[(2RS)-2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate | 含量测定 | |
| MM0282.00 | 雌激素酮 | 500mg | 12953 | Estrone | 含量测定 | |
| MM0282.01 | 雌激素酮3-甲醚 | 100mg | 12953 | Estrone 3-Methyl Ether | 含量测定 | |
| MM0286.00 | 硝酸萘甲唑啉 | 500mg | 12953 | Naphazoline Nitrate | 含量测定 | |
| MM0289.00 | 硫酸阿托品 | 500mg | 12953 | Atropine Sulphate | 含量测定 | |
| MM0289.03 | 阿托酸 | 100mg | 12953 | Atropic Acid | 含量测定 | |
| MM0289.18 | 阿托品 | 250mg | 12953 | Atropine | 含量测定 | |
| MM0290.00 | 盐酸丙嗪 | 500mg | 12953 | Promazine Hydrochloride | 含量测定 | |
| MM0290.01 | 盐酸丙嗪杂质A | 100mg | 12953 | Promazine Hydrochloride Imp. A (EP): 3-(10H-Phenothiazin-10-yl)-N,N-dimethylpropan-1-amine S-Oxide (Promazine Sulphoxide) | 含量测定 | |
| MM0291.00 | 卡维地洛 | 100mg | 12953 | Carvedilol | 含量测定 | |
| MM0291.02 | 卡维地洛杂质B | 100mg | 12953 | Carvedilol Imp. B (EP): 1,1-[[2-(2-Methoxyphenoxy)ethyl]-nitrilo]bis[3-(9H-carbazol-4-yloxy)propan-2-ol] | 含量测定 | |
| MM0291.03 | 卡维地洛杂质C | 100mg | 12953 | Carvedilol Imp. C (EP): (2RS)-1-[Benzyl[2-(2-methoxy-phenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)propan-2-ol | 含量测定 | |
| MM0291.04 | 甲苯 | 100mg | 6105 | Toluene | 含量测定 | |
| MM0294.00 | 羟甲香豆素 | 500mg | 12953 | Hymecromone | 含量测定 | |
| MM0294.01 | 间苯二酚 | 100mg | 4950 | 1,3-Dihydroxybenzene (Resorcinol) | 含量测定 | |
| MM0294.02 | 羟甲香豆素杂质B | 100mg | 12953 | Hymechromone Imp.B (EP):7-Hydroxy-2-methyl-4H-1-benzopyran-4-one | 含量测定 | |
| MM0294.04 | 羟甲香豆素乙酯 | 100mg | 12953 | Hymecromone Acetate | 含量测定 | |
| MM0295.00 | 哌拉西林 | 100mg | 12953 | Piperacillin | 含量测定 | |
| MM0296.00 | 哌拉西林钠 | 100mg | 12953 | Piperacillin Sodium | 含量测定 | |
| MM0296.05 | 哌拉西林钠杂质E | 100mg | 12953 | Piperacillin Sodium Imp. E (EP): 1-Ethylpiperazine-2,3-dione | 含量测定 | |
| MM0296.07 | 哌拉西林钠杂质G | 100mg | 12953 | Piperacillin Sodium Imp. G (EP): (2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-phenylacetic Acid | 含量测定 | |
| MM0297.00 | 氯噻酮 | 250mg | 12953 | Chlortalidone | 含量测定 | |
| MM0300.00 | 雌二醇半水合物 | 500mg | 12953 | Estradiol Hemihydrate | 含量测定 | |
| MM0300.02 | 氯噻酮杂质D | 100mg | 26235 | Estradiol Hemihydrate Imp. D (EP): Estra-1,3,5(10),9(11)-tetraene-3,17b-diol (9,11-Didehydroestradiol) | 含量测定 | |
| MM0300.03 | 6β-羟雌甾二醇 | 50mg | 26235 | 6beta-Hydroxyestradiol | 含量测定 | |
| MM0300.04 | 6α-羟雌甾二醇 | 100mg | 12953 | 6alpha-Hydroxyestradiol | 含量测定 | |
| MM0300.06 | 氯噻酮杂质C | 100mg | 12953 | Estradiol Hemihydrate Imp. C (EP): 4-Methylestra-1,3,5(10)-triene-3,17b-diol (4-Methylestradiol) | 含量测定 | |
| MM0300.08 | 6-酮雌二醇 | 100mg | 12953 | 6-Ketoestradiol | 含量测定 | |
| MM0301.00 | 苯甲酸雌二醇 | 500mg | 12953 | Estradiol Benzoate | 含量测定 | |
| MM0301.02 | 苯甲酸雌二醇杂质C | 100mg | 12953 | Estradiol Benzoate Imp. C (EP): Estra-1,3,5(10)-triene-3,17b-diyl Dibenzoate(Estradiol 3,17-Dibenzoate) | 含量测定 | |
| MM0301.03 | 苯甲酸雌二醇杂质E | 10mg | 6105 | Estradiol Benzoate Imp. E (EP): 17a-Hydroxyestra-1,3,5(10)-trien-3-yl Benzoate(17-epi-Estradiol Benzoate) | 含量测定 | |
| MM0301.07 | 苯甲酸雌二醇杂质D | 100mg | 12953 | Estradiol Benzoate Imp. D (EP): 3-Hydroxyestra-1,3,5(10)-trien-17b-yl Benzoate (Estradiol 17-Benzoate) | 含量测定 | |
| MM0301.08 | 苯甲酸雌二醇杂质G | 100mg | 12953 | Estradiol Benzoate Imp. G (EP): 17-Oxoestra-1,3,5(10)-trien-3-yl Benzoate (Estrone Benzoate) | 含量测定 | |
| MM0303.00 | 倍他米松磷酸钠 | 250mg | 12953 | Betamethasone Sodium Phosphate | 含量测定 | |
| MM0304.00 | 泼尼松龙戊酸酯 | 250mg | 26235 | Prednisolone Pivalate | 含量测定 | |
| MM0305.00 | 泼尼松龙磷酸钠 | 100mg | 12953 | Prednisolone Sodium Phosphate | 含量测定 | |
| MM0306.00 | 己曲安奈德 | 100mg | 12953 | Triamcinolone Hexacetonide | 含量测定 | |
| MM0312.00 | 氯碘羟喹 | 500mg | 12953 | Clioquinol | 含量测定 | |
| MM0312.01 | 氯碘羟喹杂质A | 100mg | 4950 | Clioquinol Imp. A (EP): 5-Chloroquinolin-8-ol | 含量测定 | |
| MM0312.02 | 氯碘羟喹杂质B | 100mg | 4950 | Clioquinol Imp. B (EP): 5,7-Dichloroquinolin-8-ol | 含量测定 | |
| MM0312.03 | 氯碘羟喹杂质C | 100mg | 4950 | Clioquinol Imp. C (EP): 5,7-Diiodoquinolin-8-ol | 含量测定 | |
| MM0313.00 | 三氯苯哒唑 | 100mg | 26235 | Triclabendazole | 含量测定 | |
| MM0314.00 | 阿司帕坦 | 500mg | 12953 | Aspartame | 含量测定 | |
| MM0314.01 | 阿司帕坦杂质A | 100mg | 12953 | Aspartame Imp. A (EP): 2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid (Diketopiperazine) | 含量测定 | |
| MM0314.02 | 阿司帕坦杂质B | 100mg | 12953 | Aspartame Imp. B (EP): L-Aspartyl-L-phenylalanine | 含量测定 | |
| MM0314.03 | 阿司帕坦杂质C | 100mg | 4950 | Aspartame Imp. C (EP): Phenylalanine | 含量测定 | |
| MM0315.00 | 盐酸哌替啶 | 100mg | 12953 | Pethidine Hydrochloride [Controlled Substance] | 含量测定 | |
| MM0315.13 | 哌替啶 | 100mg | 12953 | Prepethidine [Controlled Substance] | 含量测定 | |
| MM0317.00 | 舍曲林 | 100mg | 12953 | Sertraline | 含量测定 | |
| MM0317.01 | 舍曲林盐酸盐 | 100mg | 12953 | Sertraline Hydrochloride | 含量测定 | |
| MM0317.05 | 舍曲林杂质B | 100mg | 12953 | Sertraline Hydrochloride Imp. B (EP) as Hydrochloride: (1RS,4RS)-N-Methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride | 含量测定 | |
| MM0317.06 | 舍曲林杂质C | 100mg | 26235 | Sertraline Hydrochloride Imp. C (EP) as Hydrochloride: (1RS,4RS)-4-(4-Chlorophenyl)-N-methyl-1,2,3,4-tetrahydro-naphthalen-1-amine Hydrochloride | 含量测定 | |
| MM0317.09 | 舍曲林杂质F | 100mg | 12953 | Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative) | 含量测定 | |
| MM0318.00 | 联苯苄唑 | 500mg | 12953 | Bifonazole | 含量测定 | |
| MM0318.01 | 联苯苄唑杂质A | 100mg | 12953 | Bifonazole Imp. A (EP): (RS)-(Biphenyl-4-yl)phenylmethanol | 含量测定 | |
| MM0318.03 | 联苯苄唑杂质D | 100mg | 26235 | Bifonazole Imp. D (EP) as Chloride: 1,3-Bis[(biphenyl-4-yl)phenylmethyl]-1H-imidazolium Chloride | 含量测定 | |
| MM0319.00 | 盐酸美贝维林 | 100mg | 12953 | Mebeverine Hydrochloride | 含量测定 | |
| MM0319.01 | 盐酸美贝维林杂质D | 100mg | 4950 | Mebeverine Hydrochloride Imp. D (Pharmeuropa): 3,4-Dimethoxybenzoic Acid (Veratric Acid) | 含量测定 | |
| MM0319.02 | 盐酸美贝维林杂质A | 100mg | 4950 | Mebeverine Hydrochloride Imp. A (Pharmeuropa): 4-Methoxyphenylacetone | 含量测定 | |
| MM0319.03 | 盐酸美贝维林杂质B | 100mg | 12953 | Mebeverine Hydrochloride Imp. B (Pharmeuropa) as Hydrochloride: N-[(1RS)-1-[(4-Methoxyphenyl)methyl]ethyl]ethanamine Hydrochloride | 含量测定 | |
| MM0321.00 | 盐酸甲哌酮 | 100mg | 12953 | Melperone | 含量测定 | |
| MM0323.00 | 睾酮 | 500mg | 12953 | Testosterone | 含量测定 | |
| MM0323.01 | 睾酮杂质A | 100mg | 12953 | Testosterone Imp. A (EP): Androst-4-ene-3,17-dione (Androstenedione) | 含量测定 | |
| MM0323.02 | 睾酮杂质B | 100mg | 12953 | Testosterone Imp. B (EP): 3-Ethoxyandrosta-3,5-dien-17-one (Androstenedione Ethylenolether) | 含量测定 | |
| MM0323.03 | 睾酮杂质C | 100mg | 12953 | Testosterone Imp. C (EP): 17a-Hydroxyandrost-4-en-3-one (Epitestosterone) | 含量测定 | |
| MM0323.04 | 睾酮杂质D | 100mg | 12953 | Testosterone Imp. D (EP): Androst-4-ene-3b,17b-diol(D4-Androstenediol) | 含量测定 | |
| MM0323.07 | 睾酮杂质G | 100mg | 12953 | Testosterone Imp. G (EP): Androsta-1,4-diene-3,17-dione (Androstadienedione) | 含量测定 | |
| MM0323.12 | 睾酮杂质I | 100mg | 12953 | Testosterone Imp. I (EP): 17b-Hydroxyandrosta-4,6-dien-3-one (D6-testosterone) | 含量测定 | |
| MM0323.13 | 睾酮杂质J | 100mg | 12953 | Testosterone Imp. J (EP): 3-Methoxyandrosta-3,5-dien-17-one (Androstenedione Methylenolether) | 含量测定 | |
| MM0325.00 | 格列齐特 | 500mg | 12953 | Gliclazide | 含量测定 | |
| MM0325.02 | 格列齐特杂质B | 100mg | 12953 | Gliclazide Imp. B (EP): 2-Nitroso-octahydrocyclopenta-[c]pyrrole | 含量测定 | |
| MM0325.03 | 格列齐特杂质C | 100mg | 12953 | Gliclazide Imp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-Carbamate | 含量测定 | |
| MM0325.06 | 格列齐特杂质F | 100mg | 12953 | Gliclazide Imp. F (EP): 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea | 含量测定 | |
| MM0326.00 | 头孢克洛一水合物 | 100mg | 12953 | Cefaclor Monohydrate | 含量测定 | |
| MM0327.00 | 甲芬那酸 | 500mg | 12953 | Mefenamic Acid | 含量测定 | |
| MM0327.01 | 甲芬那酸杂质A | 100mg | 4950 | Mefenamic Acid Imp. A (EP): 2,3-Dimethylaniline | 含量测定 | |
| MM0327.02 | 甲芬那酸杂质B | 100mg | 12953 | Mefenamic Acid Imp. B (EP): N-(2,3-Dimethylphenyl)-2-[(2,3-dimethylphenyl)amino]benzamide | 含量测定 | |
| MM0330.00 | 氨甲环酸 | 500mg | 12953 | Tranexamic Acid | 含量测定 | |
| MM0330.04 | 氨甲环酸杂质D | 100mg | 4950 | Tranexamic Imp.D (EP): 4-Aminomethylbenzoic Acid | 含量测定 | |
| MM0333.01 | 酒石酸唑吡坦杂质A | 100mg | 26235 | Zolpidem Tartrate Imp. A (EP): N,N-Dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide | 含量测定 | |
| MM0333.11 | 酒石酸唑吡坦 | 100mg | 12953 | Zolpidem Tartrate [Controlled Substance] | 含量测定 | |
| MM0334.01 | 邻苯二甲酸二辛酯 | 500mg | 6105 | Diethylhexylphthalate (Bis-(2-ethylhexyl) Phthalate) | 含量测定 | |
| MM0334.08 | 水杨醛吖嗪 | 100mg | 12953 | Salicylaldehyde Azine | 含量测定 | |
| MM0336.01 | 毛地黄毒素 | 50mg | 12953 | Digitoxigenin | 含量测定 | |
| MM0337.03 | 海克替啶杂质C | 100mg | 12953 | Hexetidine Imp. C (EP): 2,6-Bis(2-ethylhexyl)-7a-methyl-hexahydro-1H-imidazo[1,5-c]imidazole (Hexedine) | 含量测定 | |
| MM0338.00 | 盐酸毛果芸香碱 | 500mg | 12953 | Pilocarpine Hydrochloride | 含量测定 | |
| MM0338.01 | 盐酸毛果芸香碱杂质A | 100mg | 12953 | Pilocarpine Hydrochloride Imp. A (EP) as Hydrochloride: (3R,4R)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one Hydrochloride (Isopilocarpine Hydrochloride) | 含量测定 | |
| MM0338.02 | 盐酸毛果芸香碱杂质B | 100mg | 12953 | Pilocarpine Hydrochloride IImp. B (EP) as Sodium Salt: (2S,3R)-2-Ethyl-3-(hydroxymethyl)-4-(1-methyl-1H-imidazol-5-yl)butanoic Acid Sodium Salt (Pilocarpic Acid Sodium Salt) | 含量测定 | |
| MM0338.03 | 盐酸毛果芸香碱杂质C | 100mg | 12953 | Pilocarpine Hydrochloride Imp. C (EP) as Sodium Salt: (2R,3R)-2-Ethyl-3-(hydroxymethyl)-4-(1-methyl-1H-imidazol-5-yl)butanoic Acid Sodium Salt (Isopilocarpic Acid Sodium Salt) | 含量测定 | |
| MM0350.00 | 诺氟沙星 | 250mg | 12953 | Norfloxacin | 含量测定 | |
| MM0350.01 | 诺氟沙星杂质A | 100mg | 12953 | Norfloxacin Imp. A (EP): 7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylicAcid | 含量测定 | |
| MM0350.03 | 诺氟沙星杂质D | 100mg | 26235 | Norfloxacin Imp. D (EP): 1-Ethyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one | 含量测定 | |
| MM0350.04 | 诺氟沙星杂质G | 100mg | 26235 | Norfloxacin Imp. G (EP): 1-Ethyl-6-fluoro-7-(4-formyl-piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid | 含量测定 | |
| MM0352.03 | 富马酸二甲酯 | 100mg | 12953 | Monomethyl Fumarate | 含量测定 | |
| MM0354.00 | 愈创木酚甘油醚 | 500mg | 12953 | Guaifenesin | 含量测定 | |
| MM0354.01 | 愈创木酚甘油醚杂质B | 100mg | 12953 | Guaifenesin Imp. B (EP): 2-(2-Methoxyphenoxy)propane-1,3-diol (B-Isomer) | 含量测定 | |
| MM0354.02 | 愈创木酚甘油醚杂质C | 100mg | 12953 | Guaifenesin Imp. C (EP): 1,1-Oxybis[3-(2-methoxyphenoxy)propan-2-ol](Bisether) | 含量测定 | |
| MM0354.03 | 愈创木酚甘油醚杂质D | 100mg | 12953 | Guaifenesin Imp. D (EP): 1,3-Bis(2-methoxyphenoxy)-propan-2-ol | 含量测定 | |
| MM0354.04 | 愈创木酚 | 500mg | 12953 | 2-Methoxyphenol (Guaiacol) | 含量测定 | |
| MM0362.00 | 盐酸氮卓斯汀 | 100mg | 12953 | Azelastine Hydrochloride | 含量测定 | |
| MM0362.01 | 盐酸氮卓斯汀杂质D | 100mg | 12953 | Azelastine Hydrochloride Imp. D (EP): 4-(4-Chlorobenzyl)phthalazin-1(2H)-one | 含量测定 | |
| MM0362.04 | 盐酸氮卓斯汀杂质A | 100mg | 6105 | Azelastine HCl Imp. A (EP): Benzoyldiazane (Benzohydrazide) | 含量测定 | |
| MM0362.05 | 盐酸氮卓斯汀杂质C | 100mg | 12953 | Azelastine Hydrochloride Imp. C (EP): 2-[(4-Chlorophenyl)acetyl]benzoic Acid | 含量测定 | |
| MM0362.06 | 盐酸氮卓斯汀杂质E | 100mg | 12953 | Azelastine Hydrochloride Imp. E (EP) Z-Isomer: (Z)-3-(4-Chlorobenzylidene)-isobenzofuran-1(3H)-one | 含量测定 | |
| MM0368.00 | 盐酸甲哌卡因 | 500mg | 12953 | Mepivacaine Hydrochloride | 含量测定 | |
| MM0368.06 | 甲哌卡因氮氧化物 | 100mg | 12953 | Mepivacaine N-Oxide | 含量测定 | |
| MM0369.00 | 盐酸阿替卡因 | 100mg | 12953 | Articaine Hydrochloride | 含量测定 | |
| MM0369.01 | 盐酸阿替卡因杂质A | 100mg | 12953 | Articaine Hydrochloride Imp. A (EP) as Hydrochloride: Methyl 3-[[2-(Propylamino)acetyl]amino]-4-methyl-thiophene-2-carboxylate Hydrochloride(Acetamidoarticaine Hydrochloride) | 含量测定 | |
| MM0369.02 | 盐酸阿替卡因杂质B | 50mg | 12953 | Articaine Hydrochloride Imp. B (EP) as Hydrochloride: 4-Methyl-3-[[(2RS)-2-(propylamino)propanoyl]amino]-thiophene-2-carboxylic Acid Hydrochloride(Articaine Acid Hydrochloride) | 含量测定 | |
| MM0369.03 | 盐酸阿替卡因杂质C | 100mg | 12953 | Articaine Hydrochloride Imp. C (EP) as Hydrochloride: 1-Methyl-ethyl 4-Methyl-3-[[(2RS)-2-(propylamino)-propanoyl]amino]thiophene-2-carboxylateHydrochloride (Articaine Isopropyl Ester Hydrochloride) | 含量测定 | |
| MM0369.04 | 盐酸阿替卡因杂质D | 10mg | 4950 | Articaine Hydrochloride Imp. D (EP) as Hydrochloride: Methyl 3-[[(2RS)-2-(Ethylamino)propanoyl]amino]-4-methylthiophene-2-carboxylateHydrochloride (Ethylarticaine Hydrochloride) | 含量测定 | |
| MM0369.05 | 盐酸阿替卡因杂质E | 100mg | 12953 | Articaine Hydrochloride Imp. E (EP) as Hydrochloride: Methyl 4-Methyl-3-[[(2RS)-2-[(1-methylethyl)amino]-propanoyl]amino]thiophene-2-carboxylateHydrochloride (IsopropylarticaineHydrochloride) | 含量测定 | |
| MM0369.06 | 盐酸阿替卡因杂质F | 50mg | 12953 | Articaine Hydrochloride Imp. F (EP) as Hydrochloride: 4-Methyl-N-propyl-3-[[(2RS)-2-(propylamino)-propanoyl]amino]thiophene-2-carboxamide Hydrochloride (Articaine Acid Propionamide Hydrochloride) | 含量测定 | |
| MM0369.07 | 盐酸阿替卡因杂质G | 100mg | 12953 | Articaine Hydrochloride Imp. G (EP) as Hydrochloride: Methyl3-[[(2RS)-2-(Butylamino)propanoyl]amino]-4-methylthiophene-2-carboxylate Hydro-chloride (Butylarticaine Hydrochloride) | 含量测定 | |
| MM0369.08 | 盐酸阿替卡因杂质H | 100mg | 12953 | Articaine Hydrochloride Imp. H (EP) as Hydrochloride: Methyl 3-[[(2RS)-2-(Dipropylamino)propanoyl]-amino]-4-methylthiophene-2-carboxylate Hydrochloride (Dipropylarticaine Hydrochloride) | 含量测定 | |
| MM0369.09 | 盐酸阿替卡因杂质I | 100mg | 6105 | Articaine Hydrochloride Imp. I (EP): Methyl 3-Amino-4-methylthiophene-2-carboxylate (3-Aminoarticaine) | 含量测定 | |
| MM0369.10 | 盐酸阿替卡因杂质J | 10mg | 4950 | Articaine Hydrochloride Imp. J (EP): Methyl 3-[[(2RS)-2-Bromopropanoyl]amino]-4-methylthiophene-2-carboxylate(Bromo Compound) | 含量测定 | |
| MM0370.01 | 反式-肉桂酸甲酯 | 100mg | 4950 | Methyl trans-Cinnamate | 含量测定 | |
| MM0371.00 | 盐酸氢吗啡酮 | 100mg | 12953 | Hydromorphone Hydrochloride [Controlled Substance] | 含量测定 | |
| MM0373.00 | 萘呋胺酯草酸盐 | 500mg | 12953 | Naftidrofuryl Hydrogen Oxalate | 含量测定 | |
| MM0377.00 | 美伐他汀 | 100mg | 12953 | Mevastatin | 含量测定 | |
| MM0378.00 | 尼美舒利 | 250mg | 12953 | Nimesulide | 含量测定 | |
| MM0378.01 | 尼美舒利杂质A | 100mg | 12953 | Nimesulide Imp. A (EP): N-(2,4-Dinitro-6-phenoxyphenyl)methanesulphonamide | 含量测定 | |
| MM0378.02 | 尼美舒利杂质B | 100mg | 12953 | Nimesulide imp. B (EP): N-(2-Phenoxyphenyl)methanesulphonamide | 含量测定 | |
| MM0378.03 | 尼美舒利杂质C | 100mg | 12953 | Nimesulide Imp. C (EP): 2-Phenoxyaniline | 含量测定 | |
| MM0378.04 | 尼美舒利杂质D | 100mg | 12953 | Nimesulide Imp. D (EP): 4-Nitro-2-phenoxyaniline | 含量测定 | |
| MM0378.05 | 尼美舒利杂质E | 100mg | 12953 | Nimesulide Imp. E (EP): N,N-Bis(methylsulphonyl)-2-phenoxyaniline | 含量测定 | |
| MM0378.06 | 尼美舒利杂质F | 100mg | 12953 | Nimesulide Imp. F (EP): N,N-Bis(methylsulphonyl)-4-nitro-2-phenoxyaniline | 含量测定 |
相关产品推荐
